GW Pharmaceuticals PLC ADR (GWPH)

NASDAQ
219.01
0.00(0.00%)
  • Volume:
    0
  • Day's Range:
    218.60 - 219.45
  • 52 wk Range:
    218.60 - 219.54
Trading near 52-week Low

GW Pharma ADR has hit the lowest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

GWPH Overview

Prev. Close
218.96
Day's Range
218.6-219.45
Revenue
559.04M
Open
219.31
52 wk Range
218.6-219.54
EPS
-2.22
Volume
0
Market Cap
6.91B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
422,473
P/E Ratio
-
Beta
1.7
1-Year Change
0.02%
Shares Outstanding
31,544,662
Next Earnings Date
-
What is your sentiment on GW Pharma ADR?
or
Market is currently closed. Voting is open during market hours.

GW Pharmaceuticals PLC ADR News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade
  • GW Pharma ADR Earnings, Revenue Miss in Q1
    • ByInvesting.com-

    Investing.com - GW Pharma (NASDAQ:GWPH) ADR reported on Monday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations. GW Pharma ADR...

  • GW Pharma ADR Earnings Miss, Revenue Beats In Q4
    • ByInvesting.com-

    Investing.com - GW Pharma (NASDAQ:GWPH) ADR reported on Tuesday fourth quarter earnings that missed analysts' forecasts and revenue that topped expectations. GW Pharma ADR...

  • Dow Ends Flat as Tech Gains Fade Into Close
    • ByInvesting.com-
    • 1

    By Yasin Ebrahim Investing.com – The Dow gave up some gains late Wednesday, as tech pulled back into the close, but hopes for further stimulus kept the downside momentum in check. ...

GW Pharmaceuticals PLC ADR Analysis

GW Pharmaceuticals PLC ADR Company Profile

GW Pharmaceuticals PLC ADR Company Profile

Employees
1161

As of May 5, 2021, operates as a subsidiary of Jazz Pharmaceuticals plc.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellNeutralBuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyStrong Buy
SummaryStrong SellStrong SellSellStrong BuyStrong Buy
  • 3 weeks now, absolutely no movement whatsoever.
    0
    • JA/ZZ bought this company out - both are going under
      1
      • bubbles . sell
        2
        • sell or you will lose money like in gme
          2
          • sell?! are you crazy?! it haven't hit it stride.
            0
        • puts????
          0
          • idk bro its up to you
            0
          • Zachary Marascothanks bro
            0
        • I bought some time ago and meant to keep it for long time, but I am thinking, should I take the profit now? And reinvest when drops?
          2
          • defo
            1
        • Woot woot!!!
          0
          • going up now
            0
            • it seems we are on the major support
              0
              • As all wait Zynerba’s Zygel FDA approval for Fragile X, GW is a bit depressed of course. I think this depression will continue till that, and after approval GW and Zynerba will grow together.
                0
                • *think
                  0
                • Sure. But for Zynerba more, because their solution better tolerated and has weaker side effects (and their market cap looks undervalued). But more approved drugs with CBD - stronger potential for the whole market.
                  0
                • I think also as both companies will reach plase 3 in ASD, this huge market will asquire all the players
                  0